U.S., Oct. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07220564) titled 'A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A' on Oct. 22.
Brief Summary: This study will test how different doses of study medicine (Inno8) work in the bodies of people with haemophilia A. The purpose of the study is to see if Inno8 is safe to use for people with haemophilia A. The study medicine is a new medicine that cannot yet be prescribed by doctors. The study will last for about 11 weeks.
Study Start Date: Oct. 23
Study Type: INTERVENTIONAL
Condition:
Haemophilia A
Intervention:
DRUG: NNC0442-0344 A
NNC0442-0344 A will be administered orally.
Re...